概述

  • 产品名称Anti-DCTN1抗体
    参阅全部 DCTN1 一抗
  • 描述
    兔多克隆抗体to DCTN1
  • 特异性Reacts specifically with 141 kDa DCTN1 protein from Drosophila melanogaster.
  • 经测试应用适用于: IHC-P, IHC-Fr, WBmore details
  • 种属反应性
    与反应: Drosophila melanogaster
  • 免疫原

    Synthetic peptide derived from the N terminal domain of DCTN1 (Drosophila melanogaster)

性能

应用

Our Abpromise guarantee covers the use of ab80257 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
IHC-P Use at an assay dependent concentration.
IHC-Fr Use at an assay dependent concentration.
WB 1/500 - 1/5000. Predicted molecular weight: 142 kDa.

靶标

  • 功能Required for the cytoplasmic dynein-driven retrograde movement of vesicles and organelles along microtubules. Dynein-dynactin interaction is a key component of the mechanism of axonal transport of vesicles and organelles.
  • 组织特异性Brain.
  • 疾病相关Defects in DCTN1 are the cause of distal hereditary motor neuronopathy type 7B (HMN7B) [MIM:607641]; also known as progressive lower motor neuron disease (PLMND). HMN7B is a neuromuscular disorder. Distal hereditary motor neuronopathies constitute a heterogeneous group of neuromuscular disorders caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs.
    Defects in DCTN1 are a cause of susceptibility to amyotrophic lateral sclerosis (ALS) [MIM:105400]. ALS is a neurodegenerative disorder affecting upper and lower motor neurons, and resulting in fatal paralysis. Sensory abnormalities are absent. Death usually occurs within 2 to 5 years. The etiology is likely to be multifactorial, involving both genetic and environmental factors.
    Defects in DCTN1 are the cause of Perry syndrome (PERRYS) [MIM:168605]; also called parkinsonism with alveolar hypoventilation and mental depression. Perry syndrome is a neuropsychiatric disorder characterized by mental depression not responsive to antidepressant drugs or electroconvulsive therapy, sleep disturbances, exhaustion and marked weight loss. Parkinsonism develops later and respiratory failure occurred terminally.
  • 序列相似性Belongs to the dynactin 150 kDa subunit family.
    Contains 1 CAP-Gly domain.
  • 翻译后修饰Ubiquitinated by a SCF complex containing FBXL5, leading to its degradation by the proteasome.
  • 细胞定位Cytoplasm. Cytoplasm > cytoskeleton.
  • Information by UniProt
  • 数据库链接
    • 别名
      • 150 kDa dynein associated polypeptide antibody
      • 150 kDa dynein-associated polypeptide antibody
      • DAP 150 antibody
      • DAP-150 antibody
      • DAP150 antibody
      • DCTN 1 antibody
      • DCTN1 antibody
      • DCTN1_HUMAN antibody
      • DP 150 antibody
      • DP-150 antibody
      • DP150 antibody
      • Dynactin 1 (p150 Glued (Drosophila) homolog) antibody
      • Dynactin 1 (p150 glued homolog Drosophila) antibody
      • Dynactin 1 antibody
      • Dynactin subunit 1 antibody
      • Dynactin1 antibody
      • HMN7B antibody
      • p135 antibody
      • p150 Glued (Drosophila) homolog antibody
      • p150 glued antibody
      • p150 glued homolog antibody
      • p150(GLUED) DROSOPHILA HOMOLOG OF antibody
      • p150-glued antibody
      • p150glued antibody
      see all

    Anti-DCTN1 antibody (ab80257)参考文献

    ab80257 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab80257.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"